CLN Stock Overview
Engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Clariant AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF14.40 |
| 52 Week High | CHF15.29 |
| 52 Week Low | CHF10.77 |
| Beta | 0.78 |
| 1 Month Change | 4.50% |
| 3 Month Change | 27.66% |
| 1 Year Change | 9.42% |
| 3 Year Change | -26.85% |
| 5 Year Change | -22.73% |
| Change since IPO | -25.77% |
Recent News & Updates
What Is Clariant AG's (VTX:CLN) Share Price Doing?
Apr 23
Increases to Clariant AG's (VTX:CLN) CEO Compensation Might Cool off for now
Apr 03Recent updates
What Is Clariant AG's (VTX:CLN) Share Price Doing?
Apr 23Increases to Clariant AG's (VTX:CLN) CEO Compensation Might Cool off for now
Apr 03An Intrinsic Calculation For Clariant AG (VTX:CLN) Suggests It's 50% Undervalued
Nov 22Clariant (VTX:CLN) Takes On Some Risk With Its Use Of Debt
Oct 31Clariant (VTX:CLN) Seems To Use Debt Quite Sensibly
Jul 30Is Now The Time To Look At Buying Clariant AG (VTX:CLN)?
May 12These 4 Measures Indicate That Clariant (VTX:CLN) Is Using Debt Reasonably Well
Apr 08Should You Think About Buying Clariant AG (VTX:CLN) Now?
Dec 23We Think Clariant (VTX:CLN) Can Stay On Top Of Its Debt
Dec 05Why Clariant AG (VTX:CLN) Could Be Worth Watching
Sep 23Is It Time To Consider Buying Clariant AG (VTX:CLN)?
May 17At CHF17.29, Is It Time To Put Clariant AG (VTX:CLN) On Your Watch List?
Feb 15Should You Think About Buying Clariant AG (VTX:CLN) Now?
Nov 07Is Clariant (VTX:CLN) Using Too Much Debt?
Oct 03Should You Investigate Clariant AG (VTX:CLN) At CHF18.84?
Aug 01Here's Why Clariant (VTX:CLN) Can Manage Its Debt Responsibly
May 20Why Clariant AG (VTX:CLN) Could Be Worth Watching
Apr 29Does Clariant AG's (VTX:CLN) Weak Fundamentals Mean That The Stock Could Move In The Opposite Direction?
Mar 04A Look At Clariant's (VTX:CLN) Share Price Returns
Feb 11
Shareholder Returns
| CLN | CH Chemicals | CH Market | |
|---|---|---|---|
| 7D | -4.1% | -1.9% | 0.3% |
| 1Y | 9.4% | 16.2% | 1.8% |
Return vs Industry: CLN underperformed the Swiss Chemicals industry which returned 16.4% over the past year.
Return vs Market: CLN exceeded the Swiss Market which returned 0.2% over the past year.
Price Volatility
| CLN volatility | |
|---|---|
| CLN Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 2.6% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in CH Market | 7.2% |
| 10% least volatile stocks in CH Market | 1.9% |
Stable Share Price: CLN has not had significant price volatility in the past 3 months.
Volatility Over Time: CLN's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1886 | 10,481 | Conrad Keijzer | www.clariant.com |
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide. The Care Chemicals segment offers specialty chemicals and application solutions for various applications in automotive fluids, aviation, construction chemicals, crop solutions, health care, home care, industrial lubricants, paints and coatings, personal care, and special solvents. The Catalysis segment provides catalyst products for use as ammonia cracking, ammonia, custom catalysts, ethylene and derivatives, fischer-tropsch, fuel cell, fuel upgrading, gas processing, hydrogen, hydrogenation, liquid hydrogen carrier, low-carbon ammonia, low-carbon methanol, methanol, methanol-to-propylene, off-gas treatment, olefins purification, on-purpose propylene, oxidation, polypropylene, refinery stream purification, styrene, zeolite powders, biocatalysis, cellulosic ethanol, cellulosic sugars, low-carbon advanced biofuels, and residue-derived biochemical intermediates.
Clariant AG Fundamentals Summary
| CLN fundamental statistics | |
|---|---|
| Market cap | CHF4.74b |
| Earnings (TTM) | CHF168.00m |
| Revenue (TTM) | CHF4.38b |
28.2x
P/E Ratio1.1x
P/S RatioIs CLN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLN income statement (TTM) | |
|---|---|
| Revenue | CHF4.38b |
| Cost of Revenue | CHF3.18b |
| Gross Profit | CHF1.20b |
| Other Expenses | CHF1.03b |
| Earnings | CHF168.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 30, 2024
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 27.42% |
| Net Profit Margin | 3.84% |
| Debt/Equity Ratio | 50.4% |
How did CLN perform over the long term?
See historical performance and comparison